J. Goldman & Co’s Zymeworks ZYME Stock Holding History

J. Goldman & Co’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-87,000	Closed	-$2.53M	–	462
2021 Q3	$2.53M	Buy	+87,000	New	+$2.89M	0.13%	174

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

J. Goldman & Co's ZYME Position: Q4 2024 in Review

J. Goldman & Co sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 119,956 shares — an estimated $1.51M sold.

J. Goldman & Co first reported a position in ZYME in Q2 2018 and held it in 8 quarters. The position peaked at $2.36M in Q2 2021. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

J. Goldman & Co reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
J. Goldman & Co sold 119,956 Zymeworks shares in Q4 2024, an estimated $1.51M.
J. Goldman & Co first reported a position in Zymeworks in Q2 2018 and held it in 8 quarters.
J. Goldman & Co's Zymeworks position peaked at $2.36M in Q2 2021.
172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.